feed,title,long_url,short_url
Barron's,Pfizer's Xeljanz Faces Canadian Review Amid More Scrutiny of JAK Inhibitors,https://www.barrons.com/articles/pfizer-arthritis-drug-xeljanz-canada-regulator-51617804758?mod=RTA,https://j.mp/3a849wX
